John Mendoza

Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins.

Panayotis Pantazis, Hellmuth R. Hinz, John Mendoza et al. · PubMed · 1992 · 85 citations

Medicine, Oncology, Pharmacology +13

Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.

Panayotis Pantazis, Janet Early, Anthony J. Kozielski et al. · PubMed · 1993 · 67 citations

Medicine, Oncology, Pharmacology +13

Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non‐tumorigenic and tumorigenic cells <i>in vitro</i>

Panayotis Pantazis, Anthony J. Kozielski, John Mendoza et al. · International Journal of Cancer · 1993 · 59 citations

Medicine, Oncology, Pharmacology +13

Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.

Qian Li, Claire F. Verschraegen, John Mendoza et al. · PubMed · 2004 · 59 citations

Medicine, Cancer Biology, Oncology +10

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.

Claire F. Verschraegen, Wei Hu, Yu Du et al. · PubMed · 2003 · 56 citations

Medicine, Cell Biology, Oncology +10